Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 1,320 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | S 90049 | - | - | - | - | [1] 6 6 💬1. S 90049
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | S 90049 - F36 | - | - | - | - | [1] 6 6 💬2. S 90049 - F36
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | S 90049 - F38 | - | - | - | - | [1] 6 6 💬3. S 90049 - F38
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide | - | - | - | - | [1] 46 46 💬4. S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | S-1226 | - | - | - | - | [1] 299 299 💬5. S-1226
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | S-adenosyl-L-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬6. S-adenosyl-L-methionine
| - | - | [1] 93 93 💬6. S-adenosyl-L-methionine
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | S-adenosyl-methionine (SAMe) capsules | [2] Ademetionine Ademetionine,Methionine | [2] Methionine
Methionine
,Ademetionine 💬 7. S-adenosyl-methionine (SAMe) capsules
| - | - | [1] 93 93 💬7. S-adenosyl-methionine (SAMe) capsules
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | S-Ketamin | - | - | - | - | [1] 298 298 💬8. S-Ketamin
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | S-ketamine | [2] Esketamine Esketamine,Ketamine | [2] Esketamine
Esketamine
,Ketamine 💬 9. S-ketamine
| [5] GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 9. S-ketamine | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | [1] 70 70 💬9. S-ketamine
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | S-ketamine & midazolam | [3] Esketamine Esketamine,Ketamine, Midazolam | [3] Midazolam
Midazolam
,Esketamine , Ketamine 💬 10. S-ketamine & midazolam
| [21] GABRA1 GABRA1,GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 [21] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3 ... 10. S-ketamine & midazolam
| [25] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 [25] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | [1] 70 70 💬10. S-ketamine & midazolam
|